AKUMSUpdated 4 Sept 2026, 2:20

Akums Drugs And Pharma L

AKUMSUpdated 4 Sept 2026, 2:20

Market Cap

₹12,289Cr.

Current Price

₹781

High / Low

₹797/409

Stock P/E

106

ROE4.92%

ROCE6.82%

Book Value₹154

Face Value₹2.00

Dividend Yield0.13%

About

Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	74	85	88	92	95	73	59	57	59
Inventory Days	123	93	96	67	85	91	68	92	101
Days Payable	87	60	85	63	120	82	69	100	89
Cash Conversion Cycle	110	118	99	96	61	82	58	49	71
Working Capital Days	109	103	121	89	-2	4	-11	47	67
ROCE %	—	14%	10%	8%	-71%	79%	-15%	16%	7%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 4 September 2026 at 2:20

AKUMS DRUGS AND PHARMA L (AKUMS) financials — quarterly results, P&L, cash flow, balance sheet, shareholding